Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Pestalozzi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Onkologie|September 28, 2001
Inflammatory myofibroblastic tumor with CNS involvementA Trojan, T Stallmach, S Kollias, et al.
The British Journal of Surgery|March 30, 2004
Critical evaluation of the different staging systems for hepatocellular carcinomaS Wildi, B C Pestalozzi, L McCormack, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 17, 2006
[Molecular targeted therapy]F Stenner-Liewen, A Zippelius, B C Pestalozzi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2006
Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysisM Lesurtel, B Müllhaupt, B C Pestalozzi, et al.
Praxis|September 6, 2005
[Current diagnosis and treatment of pancreatic cancer]S Heinrich, M Schäfer, P Bauerfeind, et al.
Blood|November 14, 1997
Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropeniaB C Pestalozzi, G P Krestin, U Schanz, et al.
The British Journal of Surgery|March 9, 2006
Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapyN Selzner, B C Pestalozzi, Z Kadry, et al.
European Journal of Clinical Pharmacology|May 20, 1998
Pharmacokinetic studies of mitoxantrone and one of its metabolites in serum and urine in patients with advanced breast cancerK M Rentsch, R A Schwendener, B C Pestalozzi, et al.
The British Journal of Dermatology|September 3, 2015
A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss settingK Matter-Walstra, R Braun, C Kolb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
Trastuzumab beyond progression: a cost-utility analysisK W Matter-Walstra, K J Dedes, M Schwenkglenks, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Onkologie|September 28, 2001
Inflammatory myofibroblastic tumor with CNS involvementA Trojan, T Stallmach, S Kollias, et al.
The British Journal of Surgery|March 30, 2004
Critical evaluation of the different staging systems for hepatocellular carcinomaS Wildi, B C Pestalozzi, L McCormack, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|November 17, 2006
[Molecular targeted therapy]F Stenner-Liewen, A Zippelius, B C Pestalozzi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 31, 2006
Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysisM Lesurtel, B Müllhaupt, B C Pestalozzi, et al.
Praxis|September 6, 2005
[Current diagnosis and treatment of pancreatic cancer]S Heinrich, M Schäfer, P Bauerfeind, et al.
Blood|November 14, 1997
Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropeniaB C Pestalozzi, G P Krestin, U Schanz, et al.
The British Journal of Surgery|March 9, 2006
Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapyN Selzner, B C Pestalozzi, Z Kadry, et al.
European Journal of Clinical Pharmacology|May 20, 1998
Pharmacokinetic studies of mitoxantrone and one of its metabolites in serum and urine in patients with advanced breast cancerK M Rentsch, R A Schwendener, B C Pestalozzi, et al.
The British Journal of Dermatology|September 3, 2015
A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss settingK Matter-Walstra, R Braun, C Kolb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
Trastuzumab beyond progression: a cost-utility analysisK W Matter-Walstra, K J Dedes, M Schwenkglenks, et al.
Pageof 3